Annual ROE
-78.34%
-36.52%-87.33%
31 December 2023
Summary:
Lumos Pharma annual return on equity is currently -78.34%, with the most recent change of -36.52% (-87.33%) on 31 December 2023. During the last 3 years, it has fallen by -48.73% (-164.57%).LUMO ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-182.95%
-49.73%-37.33%
30 September 2024
Summary:
Lumos Pharma quarterly return on equity is currently -182.95%, with the most recent change of -49.73% (-37.33%) on 30 September 2024. Over the past year, it has dropped by -105.09% (-134.97%).LUMO Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LUMO ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -135.0% |
| 3 y3 years | -164.6% | -512.9% |
| 5 y5 years | -124.7% | -1211.5% |
LUMO ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -204.1% | -191.6% |
Lumos Pharma ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -182.95%(+37.3%) |
| June 2024 | - | -133.22%(+26.6%) |
| Mar 2024 | - | -105.23%(+35.2%) |
| Dec 2023 | -78.34%(+87.3%) | -77.86%(+22.8%) |
| Sept 2023 | - | -63.38%(+18.9%) |
| June 2023 | - | -53.31%(-6.7%) |
| Mar 2023 | - | -57.13%(+9.8%) |
| Dec 2022 | -41.82%(+41.2%) | -52.04%(+17.2%) |
| Sept 2022 | - | -44.42%(+7.5%) |
| June 2022 | - | -41.32%(+33.0%) |
| Mar 2022 | - | -31.07%(+4.1%) |
| Dec 2021 | -29.61%(+49.3%) | -29.85%(+18.4%) |
| Sept 2021 | - | -25.22%(+57.8%) |
| June 2021 | - | -15.98%(+27.1%) |
| Mar 2021 | - | -12.57%(+83.5%) |
| Dec 2020 | -19.83%(-43.1%) | -6.85%(-6.3%) |
| Sept 2020 | - | -7.31%(-47.1%) |
| June 2020 | - | -13.81%(+34.7%) |
| Mar 2020 | - | -10.25%(-26.5%) |
| Dec 2019 | -34.86%(-13.3%) | -13.95%(-17.6%) |
| Sept 2019 | - | -16.92%(-15.1%) |
| June 2019 | - | -19.94%(-35.2%) |
| Mar 2019 | - | -30.79%(-25.1%) |
| Dec 2018 | -40.19%(-21.5%) | -41.11%(-6.8%) |
| Sept 2018 | - | -44.09%(-21.4%) |
| June 2018 | - | -56.08%(-0.9%) |
| Mar 2018 | - | -56.57%(-5.0%) |
| Dec 2017 | -51.21% | -59.52%(-1.9%) |
| Sept 2017 | - | -60.70%(+15.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2017 | - | -52.59%(-9.5%) |
| Mar 2017 | - | -58.13%(+7.8%) |
| Dec 2016 | -52.36%(+154.5%) | -53.92%(+0.4%) |
| Sept 2016 | - | -53.72%(+9.7%) |
| June 2016 | - | -48.99%(+35.1%) |
| Mar 2016 | - | -36.25%(+90.1%) |
| Dec 2015 | -20.57%(-127.3%) | -19.07%(-135.2%) |
| Sept 2015 | - | 54.22%(-22.4%) |
| June 2015 | - | 69.83%(-21.7%) |
| Mar 2015 | - | 89.22%(-11.2%) |
| Dec 2014 | 75.23%(-192.0%) | 100.42%(-305.9%) |
| Sept 2014 | - | -48.77%(-11.8%) |
| June 2014 | - | -55.32%(+2.1%) |
| Mar 2014 | - | -54.16%(-17.3%) |
| Dec 2013 | -81.78%(-4.1%) | -65.52%(-9.8%) |
| Sept 2013 | - | -72.60%(-1.9%) |
| June 2013 | - | -73.97%(-9.2%) |
| Mar 2013 | - | -81.43%(-3.0%) |
| Dec 2012 | -85.27%(+73.3%) | -83.92%(-63.5%) |
| Sept 2012 | - | -229.76%(-25.7%) |
| June 2012 | - | -309.43%(-77.2%) |
| Mar 2012 | - | -1355.56%(-779.1%) |
| Dec 2011 | -49.19%(-266.7%) | 199.62%(+383.3%) |
| Sept 2011 | - | 41.30%(-20.5%) |
| June 2011 | - | 51.96%(+115.4%) |
| Mar 2011 | - | 24.12%(+42.7%) |
| Dec 2010 | 29.50%(+27.6%) | 16.90%(+6.4%) |
| Sept 2010 | - | 15.89%(+163.1%) |
| Dec 2009 | 23.12%(-13.3%) | 6.04% |
| Dec 2008 | 26.66% | - |
FAQ
- What is Lumos Pharma annual return on equity?
- What is the all time high annual ROE for Lumos Pharma?
- What is Lumos Pharma quarterly return on equity?
- What is the all time high quarterly ROE for Lumos Pharma?
- What is Lumos Pharma quarterly ROE year-on-year change?
What is Lumos Pharma annual return on equity?
The current annual ROE of LUMO is -78.34%
What is the all time high annual ROE for Lumos Pharma?
Lumos Pharma all-time high annual return on equity is 75.23%
What is Lumos Pharma quarterly return on equity?
The current quarterly ROE of LUMO is -182.95%
What is the all time high quarterly ROE for Lumos Pharma?
Lumos Pharma all-time high quarterly return on equity is 199.62%
What is Lumos Pharma quarterly ROE year-on-year change?
Over the past year, LUMO quarterly return on equity has changed by -105.09% (-134.97%)